BiotechTube

Molgramostim + Placebo

Phase 2Completed
0 watching 0 views this week⚡ Active
47
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Autoimmune Pulmonary Alveolar Proteinosis

Conditions

Autoimmune Pulmonary Alveolar Proteinosis

Trial Timeline

Mar 21, 2016 → Sep 27, 2019

NCT ID
NCT02702180

About Molgramostim + Placebo

Molgramostim + Placebo is a phase 2 stage product being developed by Savara for Autoimmune Pulmonary Alveolar Proteinosis. The current trial status is completed. This product is registered under clinical trial identifier NCT02702180. Target conditions include Autoimmune Pulmonary Alveolar Proteinosis.

Hype Score Breakdown

Clinical
17
Activity
12
Company
5
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT02702180Phase 2Completed
NCT02468908Phase 1Completed

Competing Products

20 competing products in Autoimmune Pulmonary Alveolar Proteinosis

See all competitors
ProductCompanyStageHype Score
SatralizumabChugai PharmaceuticalPhase 3
77
SHR0302 quick release tablets + SHR0302 sustained-release tabletsJiangsu Hengrui MedicinePhase 1
33
HR19042 Capsule, Tarpeyo®, Budenofalk®Jiangsu Hengrui MedicinePhase 1
33
HR19042 CapsulesJiangsu Hengrui MedicinePhase 2
52
Enteric-coated Mycophenolate SodiumNovartisPhase 3
77
Ianalumab + PlaceboNovartisPhase 3
77
VAY736NovartisPhase 2/3
65
remibrutinibNovartisPhase 1
33
RO7049665RochePhase 2
52
rituximab (Mabthera®) + PlaceboRochePhase 3
77
NovoMix 30 + Tablet treatmentNovo NordiskPre-clinical
22
Anakinra 100Mg/0.67Ml Inj Syringe (Period 1) + Placebo injection (Period 1) + Anakinra 100Mg/0.67Ml Inj Syringe (Period 2) + Placebo injection (Period 2)Swedish Orphan BiovitrumPhase 2
51
branebrutinib + abatacept + branebrutinib placeboBristol Myers SquibbPhase 2
51
BMS-986165Bristol Myers SquibbPhase 1
32
NivolumabBristol Myers SquibbPhase 1
32
Fludarabine + Cyclophosphamide + TocilizumabBristol Myers SquibbPhase 1
32
BMS-986165 + RosuvastatinBristol Myers SquibbPhase 1
32
SAR445088SanofiPhase 1
32
BIVV020SanofiPhase 1
32
rilzabrutinibSanofiPhase 2
51

Other Products from Savara

MolgramostimPhase 3
72
Molgramostim + Placebo + Molgramostim Open-labelPhase 3
72
Vancomycin inhalation powder + Placebo inhalation powder + Vancomycin inhalation powderPhase 3
72
MolgramostimPhase 3
72
Vancomycin hydrochloride inhalation powder + Placebo inhalation powderPhase 2
47